Caption Management’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$452K Buy
+60,000
New +$609K ﹤0.01% 1440
2026
Q1
– Sell
-30,000
Closed -$432K – 1978
2025
Q4
$432K Hold
30,000
– – ﹤0.01% 1266
2025
Q3
$290K Hold
30,000
– – ﹤0.01% 1410
2025
Q2
$246K Hold
30,000
– – ﹤0.01% 1230
2025
Q1
$214K Buy
+30,000
New +$223K ﹤0.01% 1263
2024
Q3
– Sell
-15,500
Closed -$181K – 1547
2024
Q2
$181K Sell
15,500
-4,500
-23% -$70K ﹤0.01% 964
2024
Q1
$421K Sell
20,000
-25,000
-56% -$445K 0.01% 909
2023
Q4
$808K Buy
+45,000
New +$793K 0.01% 855
2023
Q2
– Sell
-27,000
Closed -$511K – 1355
2023
Q1
$511K Hold
27,000
– – 0.01% 789
2022
Q4
$612K Sell
27,000
-3,000
-10% -$67.8K 0.01% 874
2022
Q3
$794K Hold
30,000
– – 0.01% 941
2022
Q2
$741K Buy
+30,000
New +$749K 0.01% 981
2022
Q1
– Sell
-30,000
Closed -$981K – 1864
2021
Q4
$981K Sell
30,000
-62,700
-68% -$2.13M 0.01% 1058
2021
Q3
$3.89M Buy
92,700
+62,700
+209% +$2.26M 0.04% 543
2021
Q2
$1.16M Buy
30,000
+15,000
+100% +$536K 0.02% 848
2021
Q1
$512K Sell
15,000
-15,000
-50% -$640K 0.01% 798
2020
Q4
$1.36M Sell
30,000
-15,000
-33% -$524K 0.03% 541
2020
Q3
$1.24M Buy
+45,000
New +$1.47M 0.03% 567

Other funds holding RGNX

Caption Management's RGNX Position: Q3 2026 in Review

Caption Management opened a new position in Regenxbio (RGNX) in Q3 2026: 14,400 shares worth $108K. The stake represents ﹤0.01% of the portfolio and ranks #1627 among its holdings. This is a return to the name: Caption Management previously reported a position in RGNX as recently as Q3 2025.

Caption Management first reported a position in RGNX in Q3 2020 and has held it in 9 quarters since. The position peaked at $289K in Q3 2020. 174 funds tracked by Wall St. Rank hold RGNX as of Q3 2026.

  • Caption Management held 14,400 shares of Regenxbio worth $108K as of Q3 2026.
  • Regenxbio was a new Caption Management position in Q3 2026.
  • Regenxbio made up ﹤0.01% of Caption Management's portfolio in Q3 2026, its #1627 holding.
  • Caption Management first reported a position in Regenxbio in Q3 2020 and has held it in 9 quarters since.
  • Caption Management's Regenxbio position peaked at $289K in Q3 2020.
  • 174 funds tracked by Wall St. Rank held Regenxbio as of Q3 2026.

Based on Caption Management's 13F filing for Q3 2026, filed 16 Nov 2026.